logologo
QuantliQuantli

Celcuity Inc

CELC

NASDAQ

Biotechnology

$92.00

USD

+5.40 (+6.24%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $4.36B

Volume 1.3M

Price Target

$140.00$171.00

USD

The 5 analysts offering 1-year price forecasts have a max estimate of $171.00 and a min estimate of $140.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$154.40

-$8.1 vs prior

Implied Upside

+67.8%

-8.8% vs prior

Analyst Covering

5

-1 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

45%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$4.40 Gap

Median $150.00 vs avg $154.40 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

5 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

5

Hold

0

Sell

0

Strong Sell

0

5 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Swayampakula Ramakanth

HC Wainwright & Co.

Buy

Maintained

2 months ago

Plus
Plus
Plus

Eva Fortea Verdejo

Wells Fargo

Buy

Maintained

2 months ago

Plus
Plus
Plus

Alexander Nowak

Craig-Hallum

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

RLAY

Relay Therapeutics Inc

$19.86

-0.3%

DYN

Dyne Therapeutics, Inc

$25.70

-1.0%

ACAD

ACADIA Pharmaceuticals Inc

$28.24

-0.5%

LEGN

Legend Biotech Corp

$20.37

+0.5%

DNLI

Denali Therapeutics Inc

$24.40

-1.7%

PB

PBLS

Parabilis Medicines Inc

$37.07

+3.9%

TNGX

Tango Therapeutics Inc

$25.60

-0.2%